Α Multicenter Retrospective Study Evaluating Brivaracetam in the Treatment of Epilepsies in Clinical Practice

• Үндсэн зохиолчид: Maria Stefanatou (Зохиогч), Eirini Vasileiadou Kapetanou (Зохиогч), Vasilios K. Kimiskidis (Зохиогч), Vasileios Papaliagkas (Зохиогч), Panagiotis Polychronopoulos (Зохиогч), Sofia Markoula (Зохиогч), Kleoniki Charisiou (Зохиогч), Dimitrios Kazis (Зохиогч), Anastasia Verentzioti (Зохиогч), Panayiotis Patrikelis (Зохиогч), Athanasia Alexoudi (Зохиогч), Stylianos Gatzonis (Зохиогч)
• Формат: Ном
• Хэвлэсэн: MDPI AG, 2021-02-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Brivaracetam (BRV) is the latest approved antiepileptic drug. The aim of the study was to evaluate the efficacy and tolerability of BRV in everyday clinical practice. In this retrospective, observational, multicenter study, data from epilepsy patients receiving BRV from January 2018 to July 2019 wer...